Market Overview

Janney Capital Initiates Coverage on Amicus Therapeutics, Inc. at Buy, Announces $7.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for FOLD

DateFirmActionFromTo
Nov 2014JP MorganMaintainsOverweight
Jul 2014Janney CapitalUpgradesNeutralBuy
Jul 2014Leerink PartnersUpgradesMarket PerformOutperform

View More Analyst Ratings for FOLD
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (FOLD)

Around the Web, We're Loving...

Get Benzinga's Newsletters